Blog
RSS FeedPosted by Michael Wonder on 31 Oct 2021
PHARMAC negotiates deal for a further COVID-19 treatment
31 October 2021 - PHARMAC has negotiated an agreement with Roche to purchase another COVID-19 treatment. ...
Posted by Michael Wonder on 10 Oct 2021
70 percent of Kiwis want Government to give PHARMAC more money - survey
10 October 2021 - New Zealanders have sent a clear message to the Government to fund medicines better or their ...
Posted by Michael Wonder on 26 Aug 2021
PHARMAC seeks feedback on a biosimilar brand of adalimumab being considered for funding
26 August 2021 - PHARMAC is considering awarding Principal Supply to a biosimilar brand of adalimumab (Amgevita) from 1 February ...
Posted by Michael Wonder on 05 Aug 2021
Treasury wanted Labour to break all health election promises bar one
5 August 2021 - Treasury told the Government to kick its election promises like funding for PHARMAC, cochlear implants, and ...
Posted by Michael Wonder on 27 Jul 2021
$3.3 million to support Australians living with a rare disease
27 July 2021 - The Australian Government is providing $3.3 million to support the approximate two million Australians living with a ...
Posted by Michael Wonder on 22 Jul 2021
NHS England unveils new Innovative Medicine Fund
21 July 2021 - NHS England has unveiled its new Innovative Medicines Fund, to ensure patients have early access to ...
Posted by Michael Wonder on 14 Jul 2021
PM speaks about COVID-19, Fiji and PHARMAC funding
14 July 2021 - Prime Minister Jacinda Ardern spoke to media after a speech at the New Zealand Institute of International ...
Posted by Michael Wonder on 03 Jun 2021
'We're not just all about the money' — PHARMAC defends why it still won't fund drug for rare children's disorder
3 June 2021 - Under-fire PHARMAC is defending the way it funds New Zealand's drugs, with the agency's director of operations, ...
Posted by Michael Wonder on 30 May 2021
PHARMAC funding will result in health poverty: advocate
30 May 2021 - A Dunedin patient rights campaigner is vowing to fight on in the wake of the Government’s ...
Posted by Michael Wonder on 25 May 2021
Dupixent (dupilumab) now publicly reimbursed in Ontario and New Brunswick for the treatment of moderate to severe atopic dermatitis
25 May 2021 - Dupixent is the only biologic medicine approved by Health Canada to treat moderate to severe atopic dermatitis. ...
Posted by Michael Wonder on 20 May 2021
Budget 2021: Health boost for PHARMAC and funding for Māori Health Authority
20 May 2021 - Health Minister Andrew Little said it was one of the biggest increases PHARMAC had ever had ...
Posted by Michael Wonder on 20 May 2021
Boring Budget 2021 reinforces two tier medicines access system in New Zealand
20 May 2021 - Announcement in the budget today of $200 million over the next four years is simply meeting the ...
Posted by Michael Wonder on 20 May 2021
PHARMAC political theatre grotesque
20 May 2021 - “It is grotesque political theatre to make people wait for the budget to get their medicines ...
Posted by Michael Wonder on 18 May 2021
PHARMAC, dental funding crucial in Budget - National Party
18 May 2021 - Thursday's Budget is being promoted as a Covid-19 Recovery Budget. ...
Posted by Michael Wonder on 12 May 2021
PHARMAC funding 'affects all New Zealanders'
12 May 2021 - Doubling the funding for drug-buying agency PHARMAC will save lives and allow more people to live ...